# Carbohydrate mediated drug delivery: Synthesis and characterization of new lipid-conjugates

**Authors:** Moghis U. Ahmad, Shoukath M. Ali, Ateeq Ahmad, Saifuddin Sheikh, Paul Chen, Imran Ahmad

PMC · DOI: 10.1016/j.dib.2015.05.026 · Data in Brief · 2015-06-17

## TL;DR

This paper presents a new method to create lipid-drug carriers that target specific receptors using carbohydrates, tested for gene delivery in cells.

## Contribution

A novel synthetic approach for cationic glycolipids with potential for targeted drug delivery is introduced.

## Key findings

- PAPM and PAPG lipid conjugates were successfully synthesized for drug targeting.
- Compound 1a showed binding inhibition with Concanavalin A using invertase enzyme.
- The lipid conjugates were tested for gene transfection in A549 cells.

## Abstract

A new synthetic methodology for cationic glycolipids using p-aminophenyl-α-d-mannopyranoside (PAPM), p-aminophenyl-α-d-galactopyranoside (PAPG) was developed. PAPM-lipids and PAPG-lipids conjugates were also synthesized for targeting drugs to receptors. A binding inhibition study of synthesized p-(dimethylamino butylamido) phenyl-α-d-mannopyranoside (1a) with Concanavalin A was performed using invertase enzyme. In addition, transfection of pSV-β-gal reporter gene with was investigated in A549 cells.

## Linked entities

- **Proteins:** LOC11419107 (uncharacterized LOC11419107)

## Full-text entities

- **Genes:** GLB1 (galactosidase beta 1) [NCBI Gene 2720] {aka EBP, ELNR1, MPS4B}
- **Diseases:** lung cancer (MESH:D008175), Cancer (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4510549/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4510549/full.md

---
Source: https://tomesphere.com/paper/PMC4510549